Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: Role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression

Gynecologic Oncology

Volumn 89, Issue 1, 2003, Pages 60-72

  Kokenyesi, Robert ^a   Murray, Karuna P ^a   Benshushan, Abraham ^a   Huntley, Edward D ^a   Kao, Ming Shian ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Collagen; Integrin; Invasion; Primary peritoneal carcinosarcoma; Proteases; Proteoglycan

Indexed keywords

CELL ADHESION MOLECULE; CHONDROITIN SULFATE; COLLAGEN TYPE 1; HEPARIN; ILOMASTAT; INTEGRIN; MESSENGER RNA; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; PROTEINASE; PROTEINASE INHIBITOR; PROTEOGLYCAN; SODIUM CHLORATE; UVOMORULIN;

ADULT; ARTICLE; CANCER CELL CULTURE; CELL CULTURE; CELL FUNCTION; CELL LINE; CELL SURFACE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; MONOLAYER CULTURE; OVARY CARCINOMA; PERITONEAL CARCINOSARCOMA; PERITONEUM CANCER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 0037386313     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(02)00152-X     Document Type: Article

References (53)

1. Garamvoelgyi E., Guillou L., Gebhard S., Salmeron S., Seematter R.J., Hadji M.H. Primary malignant mixed Mullerian tumor (metaplastic carcinoma) of the female peritoneum. Cancer. 74:1994;854-863.
2. Shen D.H., Khoo U.S., Xue W.C., Ngan H.Y., Wang J.L., Liu V.W., et al. Primary peritoneal malignant mixed Mullerian tumors. A clinicopathologic, immunohistochemical, and genetic study. Cancer. 91:2001;1052-1060.
3. Visvalingam S., Jaworski R., Blumenthal N., Chan F. Primary peritoneal mesodermal adenosarcoma report of a case and review of the literature . Gynecol Oncol. 81:2001;500-505.
4. Rose P.G., Rodriguez M., Abdul-Karim F.W. Malignant mixed mullerian tumor of the female peritoneum treatment and outcome of three cases . Gynecol Oncol. 65:1997;523-525.
5. Marchevsky A., Jacobs A.J., Deppe G., Cohen C.J. Extragenital homologous mixed Mullerian tumor. J Reprod Med. 27:1982;110-112.
6. Hasiuk A.S., Petersen R.O., Hanjani P., Griffin T.D. Extragenital malignant mixed Mullerian tumor case report and review of the literature . Am J Clin Pathol. 81:1984;102-105.
7. Ohno S., Kuwano H., Mori M., Sakata H., Mori A., Shinohara K. Malignant mixed mesodermal tumor of the peritoneum with a complete response to cyclophosphamide. Eur J Surg Oncol. 15:1989;287-291.
8. Kristensen G.B., Trope C. Epithelial ovarian carcinoma. Lancet. 349:1997;113-117.
9. Dvoretsky P.M., Richards K.A., Bonfiglio T.A. The pathology and biologic behavior of ovarian cancer. An autopsy review. Pathol Annu. 24:1989;1-24.
10. x-determinant in the dissemination potential. Jpn Cancer Res. 89:1988;923-932.
11. Cannistra S.A., Ottensmeier C., Niloff J., Orta B., DiCarlo J. Expression and function of beta 1 and alpha v beta 3 integrins in ovarian cancer. Gynecol Oncol. 58:1995;216-225.
12. Casey R.C., Skubitz A.P. CD44 and betal integrins mediate ovarian carcinoma cell migration toward extracellular matrix proteins. Clin Exp Metastasis. 18:2000;67-75.
13. Stack M.S., Ellerbroek S.M., Fishman D.A. The role of proteolytic enzymes in the pathology of epithelial ovarian carcinoma. Int J Oncol. 12:1998;569-576.
14. Fishman D.A., Bafetti L.M., Stack M.S. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human epithelial carcinoma cells. Invasion Metastasis. 16:1996;150-159.
15. Harvey W., Amlot P.L. Collagen production by human mesothelial cells in vitro. J Pathol. 139:1983;337-347.
16. Stylianou E., Jenner L.A., Davies M., Coles G.A., Williams J.D. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int. 37:1990;1563-1570.
17. Bridges J.E., Englefield P., Boyd I.E., Roche W.R., Thomas E.J. Expression of integrin adhesion molecules in normal ovary and epithelial ovarian tumors. Int J Gynecol Cancer. 5:1995;187-192.
18. Moser T., Pizzo S.V., Bafetti L.M., Fishman D.A., Stack M.S. Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the α2β1 integrin. Int J Cancer. 67:1996;695-701.
19. Fishman D.A., Kearns A., Chilukuri K., Bafetti L.M., O'Toole E.A., Georgacopoulos J., et al. Metastatic dissemination of human ovarian epithelial carcinoma is promoted by α2β1-integrin-mediated interaction with type I collagen. Invasion Metastasis. 18:1998;15-26.
20. Kokenyesi R. Ovarian carcinoma cells synthesize both chondroitin sulfate and heparan sulfate cell surface proteoglycans that mediate cell adhesion to interstitial matrix. J Cell Biochem. 83:2001;259-270.
21. Buczek-Thomas J.A., Chen N., Hasan T. Integrin-mediated adhesion and signaling in ovarian cancer cells. Cell Signal. 10:1998;55-63.
22. Strobel T., Cannistra S.A. β1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro. Gynecol Oncol. 73:1999;362-367.
23. Christofori G., Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. TIBS. 24:1999;73-76.
24. Chhieng D.C., Yee H., Cangiarella J.F., Symmans W.F., Cohen J.M. Use of E-cadherin and CD44 aids in the differentiation between reactive mesothelial cells and carcinoma cells in pelvic washings. Cancer. 90:2000;299-306.
25. Zhang X.Y., Pettengell R., Nasiri N., Kalia V., Dalgleish A.G., Barton D.P. Characteristics and growth patterns of human peritioneal mesothelial cells comparison between advanced epithelial ovarian cancer and non-ovarian cancer sources . J Soc Gynecol Investig. 6:1999;333-340.
26. Pelin K., Hirvonen A., Linnainmaa K. Expression of cell adhesion molecules and connexins in gap junctional intercellular communication deficient human mesothelioma tumor cell lines and communication competent primary mesothelial cells. Carcinogenesis. 15:1994;2673-2675.
27. Maines-Bandiera S.L., Auersperg N. Increased E-cadherin expression in ovarian surface epithelium an early step in metaplasia and dysplasia? Int J Gynecol Pathol. 16:1997;250-255.
28. Sundfeldt K., Piontkewitz Y., Ivarsson K., Nilsson O., Hellberg P., Brannstrom M., et al. E-cadherin expression in human epithelial ovarian cancer and in normal human ovary. Int J Cancer. 74:1997;275-280.
29. Wong A.S.T., Maines-Bandiera S.L., Rosen B., Wheelock M.J., Johnson K.R., Leung P.C.K., et al. Constitutive and conditional cadherin expression in cultured human ovarian surface epithelium influence of family history of ovarian cancer . Int J Cancer. 81:1999;180-188.
30. Davies B.R., Worsley S.D., Ponder B.A. Expression of E-cadherin, α-catenin and β-catenin in normal ovarian surface epithelium and epithelial ovarian cancers. Histopathology. 32:1998;69-80.
31. Veatch A.L., Carson L.F., Ramakrishnan S. Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells. Int J Cancer. 58:1994;393-399.
32. Fujimoto J., Ichigo S., Hirose R., Sakaguchi H., Tamaya T. Expression of E-cadherin and alpha- and beta-catenin mRNAs in ovarian cancers. Cancer Lett. 115:1997;207-212.
33. Mobus V.J., Gerharz C.D., Weikel W., Merk O., Dreher L., Kreienberg R., et al. Characterization of a human carcinosarcoma cell line of the ovary established after in vivo change of histologic differentiation. Gynecol Oncol. 83:2001;523-532.
34. Becker J.L., Papenhausen P.R., Widen R.H. Cytogenetic, morphologic and oncogene analysis of a cell line derived from a heterologous mixed mullerian tumor of the ovary. In Vitro Cell Dev Biol. 33:1997;325-331.
35. van Haaften-Day C., Russell P., Carr S., Wright L. Development and characterization of a human cell line from an ovarian mixed mullerian tumor (carcinosarcoma). In Vitro Cell Dev Biol. 24:1988;965-971.
36. Crickard K., Niedbala J., Crickard U., Yoonessi M., Sandberg A.A., Okuyama K., et al. Characterization of human ovarian and endometrial carcinoma cell lines established on extracellular matrix. Gynecol Oncol. 32:1989;163-173.
37. Liebersbach B.F., Sanderson R.D. Expression of syndecan-1 inhibits cell invasion into type I collagen. J Biol Chem. 269:1994;20013-20019.
38. Kato M., Saunders S., Nguyen H., Bernfield M. Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. Mol Biol Cell. 6:1995;559-576.
39. Chapdelaine P., Vignola K., Fortier M.A. Protein estimation directly from SDS-PAGE loading buffer for standardization of samples from cell lysates or tissue homogenates before Western blot analysis. Biotechniques. 31:2001;477-482.
40. Fishman D.A., Chilukuri K., Stack M.S. Biochemical characterization of primary peritoneal carcinoma cell adhesion, migration, and proteinase activity. Gynecol Oncol. 67:1997;193-199.
41. Ravanti L., Heino J., Lopes-Optin C., Kahari V.M. Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase. J Biol Chem. 274:1999;2446-2455.
42. Riikonen T., Westermarck J., Koivisto L., Broberg A., Kahari V.M., Heino J. α2 integrin is a positive regulator of collagenase (MMP-1) and collagen α1(I) gene expression. J Biol Chem. 270:1995;13548-13552.
43. Ellerbroek M., Fishman D.A., Kearns A.S., Bafeti L.M., Stack M.S. Ovarian cacinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through β1 integrin. Cancer Res. 59:1999;1635-1661.
44. Leto G., Pizzolanti G., Tumminello F.M., Gebbia N. Effects of E-64 (cysteine-proteinase inhibitor) and pepstatin (aspartyl-proteinase inhibitor) on metastasis formation in mice with mammary and ovarian tumors. In Vivo. 8:1994;231-236.
45. Warwas M., Haczynska H., Gerber J., Nowak M. Cathepsin B-like activity as a serum tumour marker in ovarian carcinoma. Eur J Clin Chem Clin Biochem. 35:1997;301-304.
46. McDonnel A.C., Murdoch W.J. High-dose progesterone inhibition of urokinase secretion and invasive activity by SKOV-3 ovarian carcinoma cells evidence for a receptor-independent nongenomic effect on the plasma membrane . J Steroid Biochem Mol Biol. 78:2001;185-191.
47. Obata N.H., Tamakoshi K., Shibata K., Kikkawa F., Tomoda Y. Effects of interleukin-6 on in vitro cell attachment, migration and invasion of human ovarian carcinoma. Anticancer Res. 17:1997;337-342.
48. Westerlund A., Hujanen E., Puistola U., Turpeenniemi-Hujanen T. Fibroblasts stimulate human ovarian cancer cell invasion and expression of 72-kDa gelatinase A (MMP-2). Gynecol Oncol. 67:1997;76-82.
49. Kanemoto T., Martin G.R., Hamilton T.C., Fridman R. Effects of synthetic peptides and protease inhibitors on the interaction of a human ovarian cancer cell line (NIH:OVCAR-3) with a reconstituted basement membrane (Matrigel). Invasion Metastasis. 11:1991;84-92.
50. Auersperg N., Pan J., Grove B.D., Peterson T., Fidher J., Maines-Bandiera S., et al. E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium. Proc Natl Acad Sci USA. 96:1999;6249-6254.
51. Ong A., Maines-Bandiera S.L., Roskelly C.D., Auersperg N. Ovarian adenocarcinoma line derived from SV40/E-cadherin-transfected normal human ovarian surface epithelium. Int J Cancer. 85:2000;430-437.
52. Birchmeier W., Behrens J. Cadherin expression in carcinomas role in the formation of cell junctions and the prevention of invasiveness . Biochim Biophys Acta. 1198:1994;11-26.
53. Bracke M.E., Van Roy F.M., Mareel M.M. E-cadherin/catenin complex in invasion and metastasis. Gunthert U., Birchmeier W. Attempts to understand metastasis formation. 1996;123-161 Springer-Verlag, Berlin.